Device was explanted on (b)(6) 2020 and returned for analysis.Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this icd were re-investigated.All production steps were performed accordingly, and in particular the final acceptance test proved the device functions to be as specified.Next, the icd was subjected to an electrical analysis, revealing that the device could not be interrogated.Therefore, the device was opened, and the inner assembly was inspected.The measurement of the battery voltage showed a depleted battery.The visual inspection of the electronic module revealed deposits on parts of the electrical components and discoloration of various low voltage capacitors.The origin of these deposits could not be conclusively determined during analysis.The electronic module was attached to an external power supply to test the functionality of the module.Thereby, an elevated current consumption was measured.Further thorough investigation showed that the observed deposits on several electrical components created low resistance paths increasing the current consumption of the electronic module.The ability of the electronic module to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.The shock therapy capability of the icd could not be tested due to the above mentioned deposits on the electronic module.In conclusion, the clinical observation resulted from an early battery depletion caused by an elevated current consumption of the electronic module.The elevated current consumption occurred due to deposits on several electrical components.The origin of these deposits could not be conclusively determined during analysis.
|